Jaipur, Dec 6 (NationPress) The Rajasthan Medical and Health Department has ramped up its efforts against the production and distribution of counterfeit medications within the state, as reported by officials.

In a significant operation carried out late Friday night, the Food Safety and Drug Control Directorate confiscated medications valued at Rs 3.73 crore from a company based in Jaipur, officials disclosed on Saturday.

Rajasthan Food Safety Commissioner T. Shubhamangala confirmed that the confiscated items were sourced from GK Enterprises, situated in Jaipur.

Drug Controller Ajay Pathak stated that the establishment was implicated in the sale of fake and substandard medicines, including Winset-L and Algivin-M tablets, which were misleadingly labeled as products of YL Pharma, located in Baddi, Himachal Pradesh.

During an investigation, Drug Control Officer (DCO) Komal Rupchandani learned from a former partner of the firm, Giriraj Ajmera, that he had withdrawn from the partnership in 2019.

According to the Drugs and Cosmetics Act, 1940, and associated rules, any alterations in partnership necessitate the firm to apply for a new license within three months.

Nevertheless, the remaining partner, Khemchand, allegedly continued to operate without securing the essential license.

In light of these revelations, DCOs Komal Rupchandani and Ashok Kumar Meena filed a case against Khemchand for conducting pharmaceutical activities unlawfully.

Officials have indicated that legal proceedings and further investigations are in progress.

The Rajasthan government recently imposed a ban on nearly 40 specific medications after they were flagged for being substandard, and halted the distribution of all 19 medicines from Kaysons Pharma.

These measures were largely prompted by failures in quality control and incidents involving contaminated cough syrups that tragically resulted in child fatalities.

This year, the Rajasthan Medical Services Corporation (RMSC) has barred seven firms and 40 medicines after they did not comply with quality standards during inspections, marking the most extensive action since the Corporation's formation, as confirmed by officials in November.

State Medical and Health Minister Gajendra Singh Khinvsar emphasized that while the effective implementation of the Free Medicine Scheme is crucial, ensuring the supply of high-quality medicines is the paramount concern.

He noted that stringent measures are being enforced against firms that fail to adhere to quality standards, leading to the prohibition of seven firms and 40 products in 2025, a record since the establishment of the corporation.